Antoine Papiernik is the chairman and managing partner of Sofinnova Partners, a leading European venture capital firm in life sciences, specializing in healthcare and sustainability.
Papiernik has made initial investments and served as an active board member for numerous public companies, including Shockwave Medical, Actelion, ProQR, NovusPharma, Movetis, Mainstay, Pixium Vision and Stentys, Cotherix, CoreValve, Fovea, Ethical Oncology Science and Recor Medical.
Additionally, he has invested in and served on the boards of private companies such as Reflexion Medical, Pi-Cardia, Tissium, SafeHeal, Ablacare, Noema Therapeutics, Highlife and Rgenix. Papiernik has twice been recognized on the Forbes Midas List, one of just a few Europeans and life science investors to have been included on the prominent list.
Papiernik holds a B.S. from Institut Etudes Economiques Commerciales and an M.B.A. from the Wharton School of Business at the University of Pennsylvania.
What is Antoine Papiernik's net worth?
The estimated net worth of Antoine Papiernik is at least $4.10 million as of August 12th, 2022. Mr. Papiernik owns 12,251 shares of Shockwave Medical stock worth more than $4,101,022 as of November 23rd. This net worth evaluation does not reflect any other investments that Mr. Papiernik may own. Learn More about Antoine Papiernik's net worth.
How do I contact Antoine Papiernik?
Has Antoine Papiernik been buying or selling shares of Shockwave Medical?
Antoine Papiernik has not been actively trading shares of Shockwave Medical during the last quarter. Most recently, Antoine Papiernik sold 50,000 shares of the business's stock in a transaction on Friday, August 12th. The shares were sold at an average price of $288.11, for a transaction totalling $14,405,500.00. Following the completion of the sale, the director now directly owns 12,251 shares of the company's stock, valued at $3,529,635.61. Learn More on Antoine Papiernik's trading history.
Who are Shockwave Medical's active insiders?
Are insiders buying or selling shares of Shockwave Medical?
In the last year, insiders at the sold shares 21 times. They sold a total of 129,216 shares worth more than $30,809,995.81. The most recent insider tranaction occured on March, 26th when Director Laura Francis sold 1,500 shares worth more than $450,000.00. Insiders at Shockwave Medical own 3.4% of the company.
Learn More about insider trades at Shockwave Medical. Information on this page was last updated on 3/26/2024.
